Company / Cost of Revenue
IONIS PHARMACEUTICALS INC Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$15.9M
FY2025
5-year range
$4.4M / $15.9M
FY2021-FY2025
Trend
+41.9%
vs FY2024
Sector context
#67 of 85
Health Care
What the data says
IONIS PHARMACEUTICALS INC's cost of revenue of $16M is lower than 79% of companies in the Health Care sector (FY2025). Increased from $9M to $16M over the past 2 years.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of +54.3%.
Increased from $9M to $16M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +4.1%
- 5-Year CAGR
- +54.3%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 85This company $15.9M Sector average $2.0B
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +54.3%, indicating consistent growth.
- In FY2025, cost of revenue increased 41.9% year-over-year.
- Ranks #67 out of 85 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.9M | +41.9% |
| FY2024 | $11.2M | +22.8% |
| FY2023 | $9.1M | -35.3% |
| FY2022 | $14.1M | +222.0% |
| FY2021 | $4.4M | +140.9% |
| FY2020 | $1.8M | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026